Antineutrophil Cytoplasmic Antibody (ANCA) Vasculitis, Fatigue, and Treatment With Avacopan: A Case Series

By afschroeder • November 25, 2025

Schulze C. Antineutrophil Cytoplasmic Antibody (ANCA) Vasculitis, Fatigue, and Treatment With Avacopan: A Case Series. Cureus. 2025 Oct 20;17(10):e94987. doi: 10.7759/cureus.94987. PMID: 41280980; PMCID: PMC12631709.

Tags: ANCA-associated vasculitis, avacopan, chronic fatigue, complement inhibitor, mpo-anca, Nephrology, pauci-immune crescentic glomerulonephritis, Publications, small vessel vasculitis

Berger disease redux

Glassock RJ. Berger disease redux. Kidney Int. 2025 Dec;108(6):999-1001. doi: 10.1016/j.kint.2025.09.021. PMID: 41271316.

Shared decision making and decision aids in the management of kidney disease and renal replacement treatment options

Zisman-Ilani Y, Rhee CM, Ammary FA, Kalantar-Zadeh K. Shared decision making and decision aids in the management of kidney disease and renal replacement treatment options.[...]

Therapeutic Considerations in Preventing Chronic Kidney Disease

Nicholas SB, Nobakht N, Alicic RZ. Therapeutic Considerations in Preventing Chronic Kidney Disease. Annu Rev Med. 2025 Nov 21. doi: 10.1146/annurev-med-043024-013325. Epub ahead of print.[...]